Abiopharma

🔍 Drucker Mann Lindsay (Executive)

Company: Oddity Tech Ltd (ODD)

Report Date: 2026-06-30

Detailed Transactions and Holdings:

• Acquired 100,000 shares of Class A ordinary shares at $9.39 per share (Direct)
  Date: 2026-06-30 | Code: M | equity_swap_involved: 0 | shares_owned_after: 177,709.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 100,000 shares of Class A ordinary shares at $15.09 per share (Direct)
  Date: 2026-06-30 | Code: S | equity_swap_involved: 0 | shares_owned_after: 77,709.00 | transaction_form_type: 4 | Footnotes: F1, F2, F3
• Acquired 23,929 shares of Class A ordinary shares (Direct)
  Date: 2026-06-30 | Code: M | equity_swap_involved: 0 | shares_owned_after: 101,638.00 | transaction_form_type: 4
• Sold 9,602 shares of Class A ordinary shares at $15.1 per share (Direct)
  Date: 2026-06-30 | Code: S | equity_swap_involved: 0 | shares_owned_after: 92,036.00 | transaction_form_type: 4 | Footnotes: F4, F5
• Sold 100,000 shares of Stock Option (Right to Buy) at $9.39 per share (Derivative)
  Date: 2026-06-30 | Code: M | Expires: 2031-08-10 | equity_swap_involved: 0 | shares_owned_after: 326,840.00 | transaction_form_type: 4 | Footnotes: F1, F6
• Sold 23,929 shares of Restricted Stock Units (Derivative)
  Date: 2026-06-30 | Code: M | equity_swap_involved: 0 | shares_owned_after: 765,735.00 | transaction_form_type: 4 | Footnotes: F7, F7, F7

Footnotes:

• F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2026.
• F2: Represents the number of Class A ordinary shares sold in connection with the broker-assisted cashless exercise of the Stock Options reported on this Form 4.
• F3: The price reported is a weighted average price. The Class A ordinary shares were sold in multiple transactions at prices ranging from $15.00 to $15.28 per share. The reporting person undertakes to provide to ODDITY Tech Ltd. (the "Issuer"), any security holder of the Issuer or the Staff of the Securities and Exchange Commission upon request, full information regarding the number of Class A ordinary shares sold at each separate price within the range set forth herein.
• F4: Represents the number of Class A ordinary shares sold in connection with the vesting of Restricted Stock Units ("RSUs") solely to satisfy statutory tax withholding obligations incurred upon vesting.
• F5: The price reported is a weighted average price. The Class A ordinary shares were sold in multiple transactions at prices ranging from $14.89 to $15.26 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission upon request, full information regarding the number of Class A ordinary shares sold at each separate price within the range set forth herein.
• F6: This award was granted on August 12, 2021 and is fully vested.
• F7: RSUs convert into Class A ordinary shares on a one-for-one basis. Four installments of the award have vested, and the remainder will vest in approximately equal installments on the last day of every calendar month, with the last installment to vest on February 28, 2029.